Clinical Trial Update: Study of JS004 Combined With Toripalimab for Advanced Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial update evaluating JS004 in combination with toripalimab for advanced lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• JS004 (JS004)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Advanced Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED